Friday, October 10, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Ares Commercial Real Estate Downgraded to Underperform

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
Finance_ Stock Charts (2)
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

On March 4, 2024, Ares Commercial Real Estate (NYSE:ACRE) faced a downgrade from Buy to Underperform by B of A Securities analyst Eric Dray. The price target was also reduced from $11 to $7. Concerns about declining asset values in the commercial real estate sector, especially impacting ACRE’s office properties and multifamily markets, led to this decision. The company’s financial situation has been negatively affected by decreasing property values, potential credit losses, and challenges in refinancing loans maturing in 2024 and 2025. Despite offering a high yield and having a strong investment platform, the current risks associated with ACRE outweigh the potential rewards.

Ares Commercial Real Estate Corporation (ACRE) Stock Analysis and Performance Review – March 4, 2024

On March 4, 2024, Ares Commercial Real Estate Corporation (ACRE) saw some interesting movements in its stock performance. ACRE is currently trading near the bottom of its 52-week range and below its 200-day simple moving average, indicating possible downward pressure.

Despite this, ACRE saw a positive price change on March 4th, with shares increasing by $0.22 (2.92%) to close at $7.76. However, the stock dropped by $0.16 in pre-market trading, suggesting volatility.

Investors and analysts will monitor ACRE’s performance to see if the positive momentum can be sustained. Stock prices can fluctuate, so it will be interesting to see how ACRE performs in the coming days. Conducting research and consulting with a financial advisor before making investment decisions is recommended.

ACRE Stock Performance Review: Mixed Results for March 4, 2024

On March 4, 2024, ACRE stock showed mixed performances based on the latest financial data provided by CNN Money. The company reported a total revenue of $192.08 million for the past year, which represents an 11.13% increase compared to the previous year. However, the total revenue remained flat at $47.51 million for the last quarter.

In terms of net income, ACRE reported a net loss of $38.87 million for the past year, which is a significant decrease of 230.49% compared to the previous year. On the other hand, the net loss slightly improved to $39.41 million for the last quarter, showing a 0.0% increase compared to the previous quarter.

Earnings per share (EPS) for ACRE also showed a negative trend, with a reported EPS of -$0.72 for the past year, representing a decrease of 225.31% compared to the previous year. The EPS remained the same at -$0.73 for the last quarter, showing no improvement compared to the previous quarter.

Overall, the financial performance of ACRE stock on March 4, 2024, reflects a mixed picture. Investors may want to closely monitor the company’s financial performance and future outlook to make informed decisions about investing in ACRE stock.

Tags: ACRE
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Neurotechnology

Apple Unveils New MacBook Air Models with M3 Chip and Impressive Features

Biopharmaceutical

Groundbreaking Results of Nanobody Sonelokimab in Treating Hidradenitis Suppurativa

Digital platforms

Auddias Strategic Acquisition Plan Targeting Growth and Revenue Expansion

Recommended

Pickleball sports

Revolutionizing the Fan Experience MetLife Stadiums Cashless Payment Partnership with Shift4

2 years ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

6 days ago

Revolutionizing Mental Health Care Neuronetics and Transformations Care Network Forge GameChanging Partnership

2 years ago
Healthcare Services Stock Exchange

Revolutionizing Healthcare Harnessing RealWorld Data for Early Detection and Innovative Therapeutics

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BigBear.ai BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

GE Aerospace Stock Maintains Impressive Rally Amid Record Performance

T-Mobile US Sends Mixed Signals to Investors

Flying Taxi Pioneer Faces Market Reality Check

Alibaba Shares Face Divergent Analyst Views Amid Strategic AI Partnership

Salesforce Takes Aim at ServiceNow with AI-Powered Service Platform

NuCana Plunges Amid Unexplained Sell-Off

Trending

Johnson & Johnson Stock
Analysis

Johnson & Johnson Shares Surge on Regulatory Wins and Upbeat Analyst Outlook

by Robert Sasse
October 10, 2025
0

The healthcare sector is witnessing a notable divergence in performance, with Johnson & Johnson emerging as a...

RWE PK Stock

RWE Shares Gain Momentum Following Bullish Analyst Upgrades

October 10, 2025
lululemon athletica Stock

Lululemon Shares Face Investor Exodus as Major Stakeholder Exits

October 10, 2025
General Electric Stock

GE Aerospace Stock Maintains Impressive Rally Amid Record Performance

October 10, 2025
T-Mobile US Stock

T-Mobile US Sends Mixed Signals to Investors

October 10, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Johnson & Johnson Shares Surge on Regulatory Wins and Upbeat Analyst Outlook
  • RWE Shares Gain Momentum Following Bullish Analyst Upgrades
  • Lululemon Shares Face Investor Exodus as Major Stakeholder Exits

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com